526 related articles for article (PubMed ID: 8590986)
21. Nuclear factor-kappa-B inhibitor modulates the development of opioid dependence in a mouse model of naloxone-induced opioid withdrawal syndrome.
Rehni AK; Bhateja P; Singh TG; Singh N
Behav Pharmacol; 2008 May; 19(3):265-9. PubMed ID: 18469544
[TBL] [Abstract][Full Text] [Related]
22. Naloxone-precipitated withdrawal jumping in 11 inbred mouse strains: evidence for common genetic mechanisms in acute and chronic morphine physical dependence.
Kest B; Palmese CA; Hopkins E; Adler M; Juni A; Mogil JS
Neuroscience; 2002; 115(2):463-9. PubMed ID: 12421612
[TBL] [Abstract][Full Text] [Related]
23. Activation of serotonin 5-HT(2C) receptor suppresses behavioral sensitization and naloxone-precipitated withdrawal symptoms in morphine-dependent mice.
Zhang G; Wu X; Zhang YM; Liu H; Jiang Q; Pang G; Tao X; Dong L; Stackman RW
Neuropharmacology; 2016 Feb; 101():246-54. PubMed ID: 26432939
[TBL] [Abstract][Full Text] [Related]
24. Involvement of supraspinal and peripheral naloxonazine-insensitive opioid receptor sites in the expression of μ-opioid receptor agonist-induced physical dependence.
Mori T; Komiya S; Uzawa N; Inoue K; Itoh T; Aoki S; Shibasaki M; Suzuki T
Eur J Pharmacol; 2013 Sep; 715(1-3):238-45. PubMed ID: 23707904
[TBL] [Abstract][Full Text] [Related]
25. Naloxone rapidly evokes endogenous kappa opioid receptor-mediated hyperalgesia in naïve mice pretreated briefly with GM1 ganglioside or in chronic morphine-dependent mice.
Crain SM; Shen KF
Brain Res; 2007 Sep; 1167():31-41. PubMed ID: 17692296
[TBL] [Abstract][Full Text] [Related]
26. Elevation of plasma noradrenaline levels in urethane-anaesthetized rats by activation of central prostanoid EP3 receptors.
Yokotani K; Nishihara M; Murakami Y; Hasegawa T; Okuma Y; Osumi Y
Br J Pharmacol; 1995 Jun; 115(4):672-6. PubMed ID: 7582489
[TBL] [Abstract][Full Text] [Related]
27. Effects of alkaloid-rich extract from Mitragyna speciosa (Korth.) Havil. on naloxone-precipitated morphine withdrawal symptoms and local field potential in the nucleus accumbens of mice.
Cheaha D; Reakkamnuan C; Nukitram J; Chittrakarn S; Phukpattaranont P; Keawpradub N; Kumarnsit E
J Ethnopharmacol; 2017 Aug; 208():129-137. PubMed ID: 28687506
[TBL] [Abstract][Full Text] [Related]
28. Naloxone-precipitated withdrawal reveals sensitization to neurotransmitters in morphine tolerant/dependent rats.
Schulz R; Herz A
Naunyn Schmiedebergs Arch Pharmacol; 1977 Aug; 299(1):95-9. PubMed ID: 20584
[TBL] [Abstract][Full Text] [Related]
29. Prostaglandin E2-induced modification of tetrodotoxin-resistant Na+ currents involves activation of both EP2 and EP4 receptors in neonatal rat nodose ganglion neurones.
Matsumoto S; Ikeda M; Yoshida S; Tanimoto T; Takeda M; Nasu M
Br J Pharmacol; 2005 Jun; 145(4):503-13. PubMed ID: 15821755
[TBL] [Abstract][Full Text] [Related]
30. Neuropeptide trefoil factor 3 attenuates naloxone-precipitated withdrawal in morphine-dependent mice.
Wu P; Shi HS; Luo YX; Zhang RX; Li JL; Shi J; Lu L; Zhu WL
Psychopharmacology (Berl); 2014 Dec; 231(24):4659-68. PubMed ID: 24825609
[TBL] [Abstract][Full Text] [Related]
31. Inhibitory effect of nitric oxide (NO) synthase inhibitors on naloxone-precipitated withdrawal syndrome in morphine-dependent mice.
Cappendijk SL; de Vries R; Dzoljic MR
Neurosci Lett; 1993 Nov; 162(1-2):97-100. PubMed ID: 7510058
[TBL] [Abstract][Full Text] [Related]
32. micro-Opioid receptor endocytosis prevents adaptations in ventral tegmental area GABA transmission induced during naloxone-precipitated morphine withdrawal.
Madhavan A; He L; Stuber GD; Bonci A; Whistler JL
J Neurosci; 2010 Mar; 30(9):3276-86. PubMed ID: 20203187
[TBL] [Abstract][Full Text] [Related]
33. Prostaglandin E receptor subtypes involved in stimulation of gastroduodenal bicarbonate secretion in rats and mice.
Takeuchi K; Ukawa H; Furukawa O; Kawauchi S; Araki H; Sugimoto Y; Ishikawa A; Ushikubi F; Narumiya S
J Physiol Pharmacol; 1999 Jun; 50(2):155-67. PubMed ID: 10424714
[TBL] [Abstract][Full Text] [Related]
34. Role of beta-adrenoceptors in the expression of morphine withdrawal signs.
Funada M; Suzuki T; Sugano Y; Tsubai M; Misawa M; Ueda H; Misu Y
Life Sci; 1994; 54(8):PL113-8. PubMed ID: 7509021
[TBL] [Abstract][Full Text] [Related]
35. Selective regulation of RNK-16 cell matrix metalloproteinases by the EP4 subtype of prostaglandin E2 receptor.
Zeng L; An S; Goetzl EJ
Biochemistry; 1996 Jun; 35(22):7159-64. PubMed ID: 8679543
[TBL] [Abstract][Full Text] [Related]
36. Activation of EP4 receptors contributes to prostaglandin E2-mediated stimulation of renal sensory nerves.
Kopp UC; Cicha MZ; Nakamura K; Nüsing RM; Smith LA; Hökfelt T
Am J Physiol Renal Physiol; 2004 Dec; 287(6):F1269-82. PubMed ID: 15292051
[TBL] [Abstract][Full Text] [Related]
37. Venlafaxine inhibits naloxone-precipitated morphine withdrawal symptoms: Role of inflammatory cytokines and nitric oxide.
Mansouri MT; Naghizadeh B; Ghorbanzadeh B; Amirgholami N; Houshmand G; Alboghobeish S
Metab Brain Dis; 2020 Feb; 35(2):305-313. PubMed ID: 31630319
[TBL] [Abstract][Full Text] [Related]
38. alpha N-acetyl human beta-endorphin-(1-31) alleviates the morphine withdrawal syndrome in rodents: a comparative study with clonidine.
Garzón J; Sánchez-Blázquez P
Life Sci; 1992; 50(26):2099-109. PubMed ID: 1608292
[TBL] [Abstract][Full Text] [Related]
39. Stimulation of PGE receptors EP2 and EP4 protects cultured neurons against oxidative stress and cell death following beta-amyloid exposure.
Echeverria V; Clerman A; Doré S
Eur J Neurosci; 2005 Nov; 22(9):2199-206. PubMed ID: 16262658
[TBL] [Abstract][Full Text] [Related]
40. Investigation of the prostaglandin E (EP-) receptor subtype mediating relaxation of the rabbit jugular vein.
Lawrence RA; Jones RL
Br J Pharmacol; 1992 Apr; 105(4):817-24. PubMed ID: 1324050
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
